Stefan Ståhl
Citeras av
Citeras av
Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
K Nord, E Gunneriusson, J Ringdahl, S Ståhl, M Uhlén, PÅ Nygren
Nature biotechnology 15 (8), 772-777, 1997
Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support
T Hultman, S Stahl, E Homes, M Uhlen
Nucleic acids research 17 (13), 4937-4946, 1989
Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications
J Löfblom, J Feldwisch, V Tolmachev, J Carlsson, S Ståhl, FY Frejd
FEBS letters 584 (12), 2670-2680, 2010
Tumor imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova, M Magnusson, TLJ Eriksson, M Nilsson, B Larsson, ...
Cancer research 66 (8), 4339-4348, 2006
Affinity fusion strategies for detection, purification, and immobilization of recombinant proteins
J Nilsson, S Ståhl, J Lundeberg, M Uhlén, P Nygren
Protein expression and purification 11 (1), 1-16, 1997
Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
W Hoyer, C Grönwall, A Jonsson, S Ståhl, T Härd
Proceedings of the National Academy of Sciences 105 (13), 5099-5104, 2008
Specific binding of proinsulin C-peptide to human cell membranes
R Rigler, A Pramanik, P Jonasson, G Kratz, OT Jansson, PÅ Nygren, ...
Proceedings of the National Academy of Sciences 96 (23), 13318-13323, 1999
Selection and characterization of HER2/neu-binding affibody ligands
M Wikman, AC Steffen, E Gunneriusson, V Tolmachev, GP Adams, ...
Protein Engineering Design and Selection 17 (5), 455-462, 2004
Display of proteins on bacteria
P Samuelson, E Gunneriusson, PÅ Nygren, S Ståhl
Journal of biotechnology 96 (2), 129-154, 2002
Affibody molecules in biotechnological and medical applications
S Ståhl, T Gräslund, AE Karlström, FY Frejd, PÅ Nygren, J Löfblom
Trends in biotechnology 35 (8), 691-712, 2017
Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines
S Liljeqvist, S Ståhl
Journal of biotechnology 73 (1), 1-33, 1999
Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli
P Jonasson, S Liljeqvist, PA Nygren, S Ståhl
Biotechnology and applied biochemistry 35 (2), 91-105, 2002
Bacterial surface display: trends and progress
S Ståhl, M Uhlén
Trends in biotechnology 15 (5), 185-192, 1997
Engineering proteins to facilitate bioprocessing
PÅ Nygren, S Stefan, M Uhlén
TRENDS in Biotechnology 12 (5), 184-188, 1994
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule
M Friedman, A Orlova, E Johansson, TLJ Eriksson, I Höidén-Guthenberg, ...
Journal of molecular biology 376 (5), 1388-1402, 2008
Optimization of electroporation‐mediated transformation: Staphylococcus carnosus as model organism
J Löfblom, N Kronqvist, M Uhlén, S Ståhl, H Wernérus
Journal of applied microbiology 102 (3), 736-747, 2007
Non-immunoglobulin based protein scaffolds
J Löfblom, FY Frejd, S Ståhl
Current opinion in biotechnology 22 (6), 843-848, 2011
Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides
C Grönwall, A Jonsson, S Lindström, E Gunneriusson, S Ståhl, N Herne
Journal of biotechnology 128 (1), 162-183, 2007
Engineered affinity proteins—generation and applications
C Grönwall, S Ståhl
Journal of biotechnology 140 (3-4), 254-269, 2009
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
M Friedman, E Nordberg, I Höidén-Guthenberg, H Brismar, GP Adams, ...
Protein engineering, design & selection 20 (4), 189-199, 2007
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20